Equities

Althea Group Holdings Ltd

AGH:ASX

Althea Group Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.042
  • Today's Change-0.001 / -2.33%
  • Shares traded1.91m
  • 1 Year change+5.00%
  • Beta1.8873
Data delayed at least 20 minutes, as of Nov 13 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products. The Company operates through two business units: Althea and Peak Processing Solutions. Althea, the Company’s pharmaceutical business, offers a comprehensive range of cannabis-based medicines which are made available to patients through prescription. Peak Processing Solutions, the Company’s recreational cannabis business, produces legal cannabis products purchased by adult consumers in retail stores. The Company operates in highly regulated and legal cannabis markets across the world, with burgeoning operations in North America, Europe and Australia. The Company’s segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate).

  • Revenue in AUD (TTM)30.37m
  • Net income in AUD-32.06m
  • Incorporated2018
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nutritional Growth Solutions Ltd4.12m-4.09m5.17m--------1.25-0.1694-0.16940.1704-0.08672.082.3633.46---206.84------22.3642.47-99.30-152.300.0943-57.50----1.2641.6131.91------
Hydration Pharmaceuticals Co Ltd14.76m-11.69m5.18m--------0.3512-0.0466-0.04660.0554-0.01381.491.566.38---117.74-79.98-251.39-111.5756.0048.73-79.18-99.530.8282-4.392.42--10.3419.2723.61------
Epsilon Healthcare Ltd7.21m-5.93m7.21m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
TrivarX Ltd893.31k-1.43m8.23m4.00--0.7453--9.21-0.0045-0.00450.00270.02420.0935-------15.02-37.57-17.67-43.65100.0092.56-160.59-446.23---105.740.0016---6.99-26.3953.28--17.61--
Firebrick Pharma Ltd14.52k-1.18m11.35m----4.50--781.40-0.0066-0.00660.000080.0120.0054--0.0267---43.64-98.70-51.22-109.33-156.89---8,098.28-80,697.286.36--0.00--1,649.40--82.71------
Anatara Lifesciences Ltd0.00-1.45m12.35m----8.96-----0.0098-0.00980.000.00710.00-------93.91-76.37-126.61-88.90------------0.00------28.27------
Acrux Ltd8.10m-5.80m13.37m43.00--4.08--1.65-0.02-0.020.0280.01130.728--2.61---52.14-45.05-71.89-54.0451.14---71.62-114.01----0.5307---32.118.91-659.16---6.20--
Argent BioPharma Ltd891.08k-17.53m16.01m--------17.97-0.5116-0.51160.0241-0.11380.08580.61441.77---168.97-129.61---254.2822.86-27.15-1,969.34-667.990.1532-37.54-----73.706.3115.81---17.96--
Immuron Ltd4.90m-6.94m16.50m6.00--1.29--3.37-0.0304-0.03040.02150.05570.26121.295.43---36.96-27.01-42.53-29.3368.0674.23-141.49-245.534.87-3.030.0032--171.6715.48-83.20---37.22--
Althea Group Holdings Ltd30.37m-32.06m17.43m----55.67--0.5738-0.0858-0.08580.08080.00080.84382.347.03---89.06-37.78-167.97-47.1360.7053.83-105.54-94.470.4086-4.080.9466--20.8799.01-133.57---25.27--
Calmer Co International Ltd4.26m-3.73m17.61m--------4.13-0.0035-0.00350.0038-0.00031.132.019.14---98.45-119.20-395.42-195.4949.6239.01-87.42-219.690.5607-12.301.27--138.9287.7928.91---20.42--
Nyrada Inc3.40m-1.39m23.06m----3.97--6.78-0.0081-0.00810.02090.02770.6147-------25.13-53.28-29.75-62.52-----40.89-236.15----0.00--115.5546.4282.12------
Little Green Pharma Ltd25.63m-8.15m34.83m----0.4467--1.36-0.0272-0.02720.08560.25740.27721.0512.29---8.82---9.74--53.18---31.81--1.39-18.900.0624--29.07--4.72------
Data as of Nov 13 2024. Currency figures normalised to Althea Group Holdings Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.